Form EFFECT Maze Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2026 |
| Accession Number: | 0001193125-26-219386 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bankrate Reimagines Its Brand for the Next Generation of Consumer Advocacy
- CobbleStone Software Receives Numerous Awards in Summer 2026 Theorem LegalTech Awards
- Smoking and Vaping Incidents Fell 23% Across Dallas-Area Hotels Following City’s Indoor Vaping Ban, New Rest Data Shows
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
